Nucleic-acid mass spectrometry detection method for early screening of drive genes and susceptible genes of lung cancer
A susceptibility gene and driver gene technology, applied in the field of genetic testing, can solve the problems of incompletely including cutting-edge molecular targets, inability to achieve high-throughput detection and high-throughput analysis, and confidentiality of technical information.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0229] Example 1: Feasibility Analysis of Specific and Sensitive Gene Mutation Sites and SNPs Site Screening of Susceptibility Genes for Risk of Lung Cancer in Asian Population Individuals
[0230] The inventors of the present invention searched NCBI domestic and foreign genome-wide association study (genome-wide association study, GWAS) research literature and related patents (patent literature 6 and non-patent literature 7, etc., including but not limited to This), while searching the GWAS Catalog database and cancer-related databases such as COSMIC, CIViC, ICGC, and MYCANCER GENOME, screened out more than 1,000 positive samples from the Asian population or more than 500 positive samples from the Chinese population in the GWAS study. The inventors screened and evaluated the loci associated with the occurrence of lung cancer verified in the study, and selected 29 lung cancer hotspot mutations and 20 single nucleotide polymorphism loci that are significantly associated with the r...
Embodiment 2
[0248] Embodiment 2: Detection method of the present invention detects lung cancer cell lines
[0249] 1. Research object
[0250] Eight lung cancers with known mutation sites H460, PC9, H1650, H1975, A549, GLC82, HCC827, and H1299 (all of which can be purchased from ATCC) were selected for feasibility analysis of this detection method. ) (derived from the oral mucosa tissue extraction of normal people in Wuhan General Hospital of Guangzhou Military Region) as a negative control, water (H 2 0) as a blank control.
[0251] 2. Experimental steps
[0252] (1) Extract the DNA of the lung cancer cell line to obtain a DNA extract;
[0253] (2) Design the amplification primers of the gene mutation site and the SNPs site of the susceptibility gene used to assess the specificity and sensitivity of the individual suffering from lung cancer risk in Table 1 and Table 2 and the single base in Table 3 and Table 4 For extension primers, the amplification primers and single-base primers w...
Embodiment 3
[0289] Example 3: Detection of SNPs and mutation sites of a group of genes related to the early diagnosis of lung cancer from the peripheral blood of 26 pathologically diagnosed lung cancer patients
[0290] 1. Research object
[0291]In this study, peripheral venous blood samples from Wuhan General Hospital of Guangzhou Military Command were used to conduct genetic testing on the samples, and the number of cases was 26. The control group was a sample of healthy people from local health checkups.
[0292] 2. Experimental steps
[0293] The specific steps of applying the technology of the present invention to detect the SNPs and mutation sites of genes related to early diagnosis of lung cancer in peripheral blood samples are as follows:
[0294] (1) Obtain the subject's cfDNA sample using the Biotech Whole Blood Genomic DNA Rapid Extraction Kit
[0295] (a) Take 200 μl of collected peripheral blood and put it into a 1.5ml centrifuge tube. Add 200 μl of binding solution CB, ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com